Elena Castro

21PUBLICATIONS
95CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsClinical pharmacology and therapeuticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Dec 10, 2025
Efficacy at a cost?-quality of life implications of PARP inhibition in the homologus recombination repair (HRR) cohort of TALAPRO-2.

Jorge Esteban-Villarrubia, Elena Castro

|Aug 07, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier

|Mar 19, 2025
Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe.

Elena Castro, Chinelo Orji, Amanda Ribbands

|Mar 06, 2025
Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPC.

Elena Castro, Di Wang, Sarah Walsh

|Nov 26, 2024
Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer.

Elena Castro, Rhett Figliuzzi, Sarah Walsh

Pageof 4

Frequent Collaborators

3 joint publications

Carlo Cattrini

3 joint publications

Imtiaz A Samjoo

3 joint publications

Jonathan Nazari

2 joint publications

Anja Haltner